XTalks

NOVEMBER 21, 2024

The test, the first of its kind approved for over-the-counter (OTC) use in the US, detects antibodies for Treponema pallidum , the bacterium responsible for syphilis. Using a single drop of blood, it delivers highly accurate results, with clinical trials showing a 99.5 percent accuracy rate for negative cases and 93.4

Bacterium 104

Bacterium Antibody Manufacturing Pharmacy 104

pharmaphorum

SEPTEMBER 10, 2020

The programme is still in the early stages of development, but if it works in trials would provide another approach to prevent transmission of SARS-CoV-2, the virus that causes COVID-19, alongside vaccines and prophylactic antibodies.

Vaccine 133

Vaccine Vaccination Bacterium Antibody 133

XTalks

APRIL 15, 2025

Clinical Trial Results Blujepas approval was based on data from the Phase III EAGLE-2 and EAGLE-3 trials that enrolled over 3,000 patients. coli s unique circular DNA during transcription is highly specific to that bacterium. The two pathogens account for the vast majority of community-acquired UTIs.

FDA Approval 52

FDA Approval Bacteria DNA Bacterium 52

Pharmaceutical Technology

SEPTEMBER 1, 2022

While nucleic acid amplification tests - a type of viral diagnostic test for a virus or bacterium that detects genetic materials rather than antigens or antibodies - can provide a shorter turnaround time, they come with challenges, ranging from their complex nature to the intensity of labour required in their creation.

Manufacturing 130

Manufacturing Bacterium Reagent Production 130

XTalks

JULY 25, 2023

Anthrax is a rare, yet severe disease caused by the bacterium B. Cyfendus functions by stimulating the production of antibodies targeted against the protective antigen protein. These antibodies play a crucial role in providing protection by effectively neutralizing the cytotoxic lethal toxin and edema toxin of B. Overall, 66.3

FDA Approval 98

FDA Approval Vaccine Vaccination Antibody 98

XTalks

NOVEMBER 10, 2020

Update (November 11, 2020): Quebec-based biopharmaceutical company Medicago has announced positive results from a Phase I trial of its candidate plant-derived vaccine. Interim results of the trial show that all participants developed an antibody response after two doses of the COVID-19 adjuvanted vaccine candidate.

Vaccine 52

Vaccine Vaccination Trials Immune Response 52

pharmaphorum

JUNE 16, 2022

Around a third of patients waiting for a kidney transplant are cases as “sensitised” – meaning they have very high antibody levels to human leukocyte antigens (HLAs), which makes it more likely they will reject a donated organ. The post Hansa gets NICE okay for Idefirix in kidney transplant patients appeared first on.

Antibody 52

Antibody Bacterium Medicine Clinical Trials 52